BLUE drug approval | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  167723 of 169958  at  9/19/2022 8:27:14 PM  by

nocashonhand


 In response to msg 167704 by  NHangel
view thread

Re: BLUE drug approval

 I’d only agree that biotech is still digging out of a hole. But the specific action for BLUE is complicated with cash concerns. I am not terribly surprised at all the stock didn’t repeat the leg up today like it did first time around last month. Can you imagine how many johnny come late retailers were hoping/expecting a repeat bounce? Sell the news is not unheard of. And again recent comparisons on this board with NTLA trading down after good news as well and comparing with SGMO even over the last year or so is so flawed as well. So what SGMO has outperformed NTLA the last year; -44% to -58% respectively. 2 year performance comparison is -51% to 180% respectively. NTLA and SGMO are in completely different categories. NTLA is rolling down the highway and catching headwinds. While SGMO is unable to get out of the garage. 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...